Literature DB >> 19575021

Stomach: Quadruple therapy for Helicobacter pylori eradication.

Javier P Gisbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19575021     DOI： 10.1038/nrgastro.2009.101

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

1.  Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).

Authors:  Gerhard Treiber; Joachim Wittig; Susanne Ammon; Siegfried Walker; Leen-Jan van Doorn; Ulrich Klotz
Journal:  Arch Intern Med       Date:  2002-01-28

2.  Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection.

Authors:  A Nagahara; H Miwa; T Yamada; A Kurosawa; R Ohkura; N Sato
Journal:  Aliment Pharmacol Ther       Date:  2001-03       Impact factor: 8.171

3.  The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen.

Authors:  P M Neville; S Everett; H Langworthy; D Tompkins; N P Mapstone; A T Axon; P Moayyedi
Journal:  Aliment Pharmacol Ther       Date:  1999-04       Impact factor: 8.171

4.  A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome.

Authors:  M Okada; H Nishimura; M Kawashima; N Okabe; K Maeda; M Seo; K Ohkuma; T Takata
Journal:  Aliment Pharmacol Ther       Date:  1999-06       Impact factor: 8.171

5.  Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication.

Authors:  G Treiber; S Ammon; E Schneider; U Klotz
Journal:  Helicobacter       Date:  1998-03       Impact factor: 5.753

6.  Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy.

Authors:  A Nagahara; H Miwa; K Ogawa; A Kurosawa; R Ohkura; N Iida; N Sato
Journal:  Helicobacter       Date:  2000-06       Impact factor: 5.753

7.  Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.

Authors:  F Catalano; G Branciforte; R Catanzaro; R Cipolla; C Bentivegna; A Brogna
Journal:  Aliment Pharmacol Ther       Date:  2000-10       Impact factor: 8.171

8.  Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication.

Authors:  Abdallah Said Essa; Jennifer Rosenthal Kramer; David Y Graham; Gerhard Treiber
Journal:  Helicobacter       Date:  2009-04       Impact factor: 5.753

9.  Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.

Authors:  David Y Graham; Hong Lu; Yoshio Yamaoka
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.